To establish a prospective, multicenter, real-world cohort of patients with osteomyelitis, by systematically collecting and analyzing detailed treatment and follow-up data, in order to provide clinical evidence for the standardization of its treatment
Eligibility
Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
No
Inclusion Criteria:
1. Signed informed consent provided.
2. Diagnosis of osteomyelitis confirmed by the site per guidelines (including definitive/suggestive criteria).
Exclusion Criteria:
1. Patients who, in the opinion of the investigator, are unable to comply with the entire study procedure (including postoperative management and regular follow-up) due to psychiatric, cognitive, or behavioral disorders, or other objective reasons.
2. Any other condition that, in the opinion of the investigator, would make the patient unsuitable for participation in the study.
Primary outcome measure(s)
Infection control rate at week 8 after treat — 8 weeks after operation Patients will return for a follow-up visit at 8 weeks post-treatment. The assessment will include evaluation of the incision condition, documentation of afebrile status, and repeat laboratory tests including CBC (WBC count), ESR, and CRP
Trial sites (1)
Facility
City
Region
Status
The First Hospital Affiliated to Army Medical University
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.